KALA BIO, Inc.
KALA BIO, Inc.
Your view on KALA
Overview
What the company does, where it operates, and who runs it.
About KALA BIO, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- R. Kim Brazzell
- Headquarters
- 1167 Massachusetts Avenue, Arlington, MA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- R. Kim Brazzell
- Headquarters
- 1167 Massachusetts Avenue, Arlington, MA, US
Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.